A carregar...
Rapid Response in a Patient with Relapsed/Refractory Multiple Myeloma Treated with BRAF/MEK Inhibitors
Patients with relapsed and refractory multiple myeloma have a poor prognosis. The mitogen-activated protein kinase (MAPK) pathway has been implicated in the pathogenesis of multiple myeloma. Several mutations in this pathway can lead to its constitutive activation leading to oncogenesis. One such mu...
Na minha lista:
| Publicado no: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7748897/ https://ncbi.nlm.nih.gov/pubmed/33381330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8821415 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|